PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHyperlipoproteinemia type i
MeSH D008072 - hyperlipoproteinemia type i
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008052:Inborn errors lipid metabolism
$
Success rate
D006951:Hyperlipoproteinemias
D008072: 
Hyperlipoproteinemia type i
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Akcea TherapeuticsVolanesorsen Waylivra  2019-05-03   
UniqureAlipogene tiparvovec Glybera  2012-10-25   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
89%
8/9
Phase 3
20%
2/10
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Akcea Therapeutics
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use